Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts.
CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors, is pleased to welcome Leah Goodman to the Board of Directors.
Since late 2023, Leah Goodman has served as Chief Executive Officer of Biointelect, a leading Australian life science consultancy and CRO. She has been involved in supporting early- and late-stage biotechnology companies, as well as all levels of government and research sectors across Australia, the US, Asia, and Europe. This involvement has led to the commercialization of innovation through strategic thought and implementation which maximizes the speed of patient access. In 2025, through federal government MRFF investment, Biointelect established an incubator to support Australian SME commercialization of vaccine and infectious disease innovations.
Leah has successfully led commercial businesses across Australia, New Zealand, Japan, South Korea and various Southeast Asian markets with Sanofi, Merck KaaG and Bristol Myers Squibb.
She has a depth of experience in commercialization, business development, policy shaping, market access and regulatory affairs across a breadth of therapeutic areas including oncology and immunotherapies, as well as cell and gene therapy advanced GMP manufacturing.
Leah holds a Bachelor of Science and a Masters Degree in Commerce both from the University of NSW. She is a graduate of the Australian Institute of Company Directors (GAICD) and holds a certificate in advanced GMP manufacturing. Leah is a member of the AusBiotech NSW Leadership Council, BioNSW Commercialization committee, and was previously on the AusBiotech Cell and Gene therapy Policy and Advocacy working group.
"My excitement in joining the Providence Therapeutics Board is based on the opportunity it presents to help shape innovations that can truly transform patient lives. Throughout my career, I've seen how powerful scientific breakthroughs become when paired with thoughtful commercialization. Providence's vision aligns perfectly with my motivation to enable meaningful, accessible innovation. I'm honoured to bring my global leadership experience and deep Australian insight to support the team in delivering life‑changing therapies to patients around the world."
About Providence Therapeutics:
Founded in 2015 with headquarters in Calgary, Canada Providence Therapeutics Holdings Inc. is a clinical stage platform mRNA company with proprietary technologies and know how including: INTENT™ lipid nanoparticle delivery and expertise in mRNA design and manufacturing. Providence has multiple programs in oncology, infectious disease, and animal health.
For more information visit www.providencetherapeutics.com
Media Contact: media@providencetherapeutics.com
Photo - https://mma.prnasia.com/media2/2877441/Providence_Therapeutics_Holdings_Inc_Providence_Therapeutics_Ann.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
- Matrix successfully demonstrates full transition flight capability
- Pioneering aircraft available in 10-seat passenger and 1,500kg cargo configurations
SUZHOU, China, Feb. 5, 2026 /PRNewswire/ -- AutoFlight has unveiled Matrix, the world's first 5-ton class electric vertical take-off and landing (eVTOL) aircraft, which successfully completed a public full transition flight demonstration at the company's low-altitude flight test facility center.
During the demonstration, Matrix completed the full mode transition flight sequence, transitioning from vertical take-off through cruise flight to vertical landing. The achievement validates AutoFlight's eVTOL technologies across complex aerodynamic systems, high-power electric propulsion, and advanced flight control systems, marking the first time a 5-ton eVTOL has achieved full transition flight.
Matrix features a 20-metre wingspan, 17.1-metre length, and 3.3-metre height, with a maximum take-off weight of 5,700kg.
The aircraft will be available in passenger and cargo variants. The passenger version offers flexible seating configurations, accommodating either 10 business-class seats or six VIP seats.
The cargo variant uses hybrid power system, supporting a maximum payload of 1,500kg, and features a large forward-opening door capable of accommodating two AKE standard air cargo containers, enhancing operational efficiency for ton-scale cargo transport.
eVTOL Industry Disruptor
AutoFlight's CEO and Founder, Tian Yu said: "Matrix is not only a rising star in the aviation industry but also an ambitious industry disruptor. It will break the industry perception that eVTOL = short-haul, low-load, and will reshape the rules of eVTOL routes. Through economies of scale, it significantly reduces transportation costs per seat-kilometer and ton-kilometer, revolutionizing costs and embracing profitability. It covers all scenarios from urban commuting to intercity feeder routes, driving the expansion of the entire low-altitude ecosystem."
Design and Safety Features
Matrix employs AutoFlight's compound wing Lift and Cruise configuration with a distinctive triplane layout and six-arm structure, ensuring aerodynamic stability throughout all flight phases.
The pure electric version offers a maximum range of 250km, while the hybrid-electric variant extends range to 1,500km. The platform's capacity positions it for diverse applications including regional travel, heavy logistics operations, and large-scale emergency response missions.
AutoFlight's Strategic Development
Matrix represents a continuation of AutoFlight's product strategy, following the company's Great White Shark for industrial applications, CarryAll for autonomous logistics, and Prosperity for urban air mobility. The development program builds upon AutoFlight's accumulated expertise in low-altitude flight technology, reliability, safety systems and airworthiness certification.
SUZHOU, China, Feb. 5, 2026 /PRNewswire/ -- AutoFlight has unveiled Matrix, the world's first 5-ton class electric vertical take-off and landing (eVTOL) aircraft, which successfully completed a public full transition flight demonstration at the company's low-altitude flight test facility center.
During the demonstration, Matrix completed the full mode transition flight sequence, transitioning from vertical take-off through cruise flight to vertical landing. The achievement validates AutoFlight's eVTOL technologies across complex aerodynamic systems, high-power electric propulsion, and advanced flight control systems, marking the first time a 5-ton eVTOL has achieved full transition flight.
Matrix features a 20-metre wingspan, 17.1-metre length, and 3.3-metre height, with a maximum take-off weight of 5,700kg.
The aircraft will be available in passenger and cargo variants. The passenger version offers flexible seating configurations, accommodating either 10 business-class seats or six VIP seats.
The cargo variant uses hybrid power system, supporting a maximum payload of 1,500kg, and features a large forward-opening door capable of accommodating two AKE standard air cargo containers, enhancing operational efficiency for ton-scale cargo transport.
eVTOL Industry Disruptor
AutoFlight's CEO and Founder, Tian Yu said: "Matrix is not only a rising star in the aviation industry but also an ambitious industry disruptor. It will break the industry perception that eVTOL = short-haul, low-load, and will reshape the rules of eVTOL routes. Through economies of scale, it significantly reduces transportation costs per seat-kilometer and ton-kilometer, revolutionizing costs and embracing profitability. It covers all scenarios from urban commuting to intercity feeder routes, driving the expansion of the entire low-altitude ecosystem."
Design and Safety Features
Matrix employs AutoFlight's compound wing Lift and Cruise configuration with a distinctive triplane layout and six-arm structure, ensuring aerodynamic stability throughout all flight phases.
The pure electric version offers a maximum range of 250km, while the hybrid-electric variant extends range to 1,500km. The platform's capacity positions it for diverse applications including regional travel, heavy logistics operations, and large-scale emergency response missions.
AutoFlight's Strategic Development
Matrix represents a continuation of AutoFlight's product strategy, following the company's Great White Shark for industrial applications, CarryAll for autonomous logistics, and Prosperity for urban air mobility. The development program builds upon AutoFlight's accumulated expertise in low-altitude flight technology, reliability, safety systems and airworthiness certification.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
AutoFlight Unveils World's First 5-Ton Class eVTOL Aircraft
